Bank of New York Mellon Corp Has $22.66 Million Stake in Analogic Co. (ALOG)

Bank of New York Mellon Corp reduced its stake in Analogic Co. (NASDAQ:ALOG) by 26.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 270,518 shares of the medical research company’s stock after selling 97,065 shares during the period. Bank of New York Mellon Corp owned approximately 2.17% of Analogic worth $22,657,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of ALOG. Citadel Advisors LLC boosted its stake in Analogic by 88.8% during the second quarter. Citadel Advisors LLC now owns 128,879 shares of the medical research company’s stock valued at $9,363,000 after buying an additional 60,614 shares during the period. Renaissance Technologies LLC bought a new stake in Analogic during the first quarter valued at $1,252,000. Vanguard Group Inc. boosted its stake in Analogic by 3.1% during the second quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock valued at $83,359,000 after buying an additional 34,765 shares during the period. SG Americas Securities LLC boosted its stake in Analogic by 470.7% during the second quarter. SG Americas Securities LLC now owns 7,619 shares of the medical research company’s stock valued at $554,000 after buying an additional 6,284 shares during the period. Finally, TIAA CREF Investment Management LLC boosted its stake in Analogic by 33.1% during the second quarter. TIAA CREF Investment Management LLC now owns 56,358 shares of the medical research company’s stock valued at $4,094,000 after buying an additional 14,022 shares during the period. 97.82% of the stock is owned by hedge funds and other institutional investors.

Shares of Analogic Co. (NASDAQ:ALOG) opened at $83.75 on Friday. Analogic Co. has a 52 week low of $66.00 and a 52 week high of $88.45. The stock has a market capitalization of $1,037.48, a PE ratio of 42.62, a price-to-earnings-growth ratio of 4.15 and a beta of 0.86.

Analogic (NASDAQ:ALOG) last issued its quarterly earnings results on Wednesday, December 6th. The medical research company reported $0.75 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.43 by $0.32. Analogic had a positive return on equity of 5.09% and a negative net margin of 15.06%. The firm had revenue of $106.90 million during the quarter, compared to analyst estimates of $100.55 million. During the same quarter in the previous year, the company posted $0.43 earnings per share. The company’s revenue was down 11.7% compared to the same quarter last year. equities analysts predict that Analogic Co. will post 2.86 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 15th will be paid a dividend of $0.10 per share. This represents a $0.40 annualized dividend and a yield of 0.48%. The ex-dividend date of this dividend is Thursday, December 14th. Analogic’s dividend payout ratio (DPR) is currently -6.99%.

Several equities research analysts recently issued reports on the company. Jefferies Group reissued a “hold” rating and set a $75.00 price objective on shares of Analogic in a research note on Wednesday, September 20th. Zacks Investment Research raised Analogic from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a research note on Friday, December 8th. Finally, BidaskClub lowered Analogic from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $88.33.

TRADEMARK VIOLATION NOTICE: “Bank of New York Mellon Corp Has $22.66 Million Stake in Analogic Co. (ALOG)” was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another site, it was stolen and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://sportsperspectives.com/2017/12/15/bank-of-new-york-mellon-corp-has-22-66-million-stake-in-analogic-co-alog.html.

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Co. (NASDAQ:ALOG).

Institutional Ownership by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply